Standardized method to minimize variability in a functional P2X7 flow cytometric assay for a multi-center clinical trial
✍ Scribed by N. L. Korpi-Steiner; D. Sheerar; E. B. Puffer; C. Urben; J. Boyd; A. Guadarrama; K. Schell; L. C. Denlinger
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 432 KB
- Volume
- 74B
- Category
- Article
- ISSN
- 1552-4949
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Flow cytometric analysis of human P2X~7~ pore activity segregates variant from common P2RX7 genotypes and may serve as a biomarker for cancer, pain, inflammation, and immune responses to infection. Standardization is needed to accommodate variable sample age and instrumentation differences in a multicenter clinical trial.
Methods
CD14‐PE‐stained whole blood samples were treated with YO‐PRO‐1 combined with a P2X~7~ agonist (BzATP) or control, followed by the addition of PI after closure of the P2X~7~ pore. Recalled instrument settings from previous publications were used to adapt a standardized fluorescent particle‐adjusted set‐up method. Experiments were performed to compare the two methods while evaluating components of systematic variability and facilitating reliable processing of samples with varied ages.
Results
The median YO‐PRO‐1 fluorescence of BzATP‐treated samples had less variability when collected by the bead‐adjusted method and was less influenced by the compensation strategy used. The average day‐to‐day coefficient of variance for assessments of P2X~7~ pore activity by this method was 0.11 ± 0.04, and the exclusion of nonviable cells was found to accommodate samples aged up to 4 days after phlebotomy. The bead‐adjusted set‐up method produced measurements differing by only 2.0% ± 1.5% on two analog cytometers, and within similar decades when comparing analog to digital instruments.
Conclusions
These results provide a standardized method for quantitative flow cytometric analysis of P2X~7~ receptor phenotypes in blood monocytes with minimal intralaboratory variation and potential for interlaboratory comparisons that can greatly facilitate multicenter functional genomic clinical studies. © 2008 Clinical Cytometry Society